Publication & Citation Trends
Most Cited Works
Publications
147 total
Abstract 5183: High-throughput ex vivo TCR-T cells screening identifies aggrephagy-driven, therapy-resistant clones in KRAS-mutant PDAC
Cited by 0
Semantic Scholar
Therapeutic scheduling of WEE1 inhibition preserves T cell function and promotes immune control of HPV+ tumors
Cited by 0
Semantic Scholar
Antigen-specific profiling identifies T-bet+ melanoma-specific CD8+ T cells associated with response to neoadjuvant PD-1 blockade.
Cited by 1
Semantic Scholar
LOXHD1 is an oncofusion-regulated antigen of ewing sarcoma
Cited by 2
Semantic Scholar
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models.
Cited by 39
Semantic Scholar
Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy.
Cited by 15
Semantic Scholar
398 Functional characterization of a class I-restricted CD8+ T cell receptor specific for the stem cell transcription factor Sox2 OA
Cited by 0
Semantic Scholar
CD5 deletion enhances the antitumor activity of adoptive T cell therapies
Cited by 38
Semantic Scholar
Research Topics
Immunotherapy and Immune Responses
(66)
Immune Cell Function and Interaction
(48)
T-cell and B-cell Immunology
(46)
Cancer Immunotherapy and Biomarkers
(35)
CAR-T cell therapy research
(35)
Frequent Co-Authors
Affiliations
Barnes-Jewish Hospital
Naval Medical Research Command
Tokai University
Howard Hughes Medical Institute
Pfizer (United States)